Sarena Francis Willard
Chief Strategy Officer at FIVE PRIME THERAPEUTICS INC
- Sold, on record
- $3.8M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 18, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- FIVE PRIME THERAPEUTICS INCChief Strategy Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale FIVE PRIME THERAPEUTICS INCUnusualJan 27, 2016 2016
Sold 30,000 shares at $35.22 ($1.1M)
Sarena Francis Willard, EVP, Gen Counsel & Secretary
Sold 26.4% of holdings ($4M position)83,570 shares leftFirst sale on recordFiling
- 2 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedMar 30, 2016 +63 days
Sold 10,000 shares at $40.01 ($400k)
Sarena Francis Willard, EVP, Gen Counsel and Secretary
Sold 10.7% of holdings ($3.8M position)83,834 shares leftFiling
- 3 Form 4 sale FIVE PRIME THERAPEUTICS INCUnusualNov 25, 2016 +240 days
Sold 34,654 shares at $60.38 ($2.1M)
Sarena Francis Willard, Chief Strategy Officer
Sold 29.9% of holdings ($7M position)81,266 shares leftFiling
- 4 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedNov 28, 2016 +3 days
Sold 1,710 shares at $60.14 ($103k)
Sarena Francis Willard, Chief Strategy Officer
Sold 2.1% of holdings ($5M position)81,266 shares left0.1x usual sizeFiling
- 5 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedJan 18, 2017 +51 days
Sold 3,636 shares at $47.39 ($172k)
Sarena Francis Willard, Chief Strategy Officer
Sold 4.4% of holdings ($3.9M position)78,824 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2017 | Jan 18, 2017 | FIVE PRIME THERAPEUTICS INC | Chief Strategy Officer | Form 4 sale | 3,636 | $172k | 4.4% | Plan not stated | SEC |
| Nov 28, 2016 | Nov 30, 2016 | FIVE PRIME THERAPEUTICS INC | Chief Strategy Officer | Form 4 sale | 1,710 | $103k | 2.1% | Plan not stated | SEC |
| Nov 25, 2016 | Nov 28, 2016 | FIVE PRIME THERAPEUTICS INC | Chief Strategy Officer | Form 4 sale | 34,654 | $2.1M | 29.9% | Unusual | SEC |
| Mar 30, 2016 | Mar 31, 2016 | FIVE PRIME THERAPEUTICS INC | EVP, Gen Counsel and Secretary | Form 4 sale | 10,000 | $400k | 10.7% | Plan not stated | SEC |
| Jan 27, 2016 | Jan 29, 2016 | FIVE PRIME THERAPEUTICS INC | EVP, Gen Counsel & Secretary | Form 4 sale | 30,000 | $1.1M | 26.4% | Unusual | SEC |